MAPK1 and lung carcinoma: The TCGA lung cancer database analysis (N = 514) revealed that both EGFR/ERK2 (MAPK1) expression is significantly increased in patients with lung cancer, with a correlation coefficient value of 0.2508 (Figure 1A).